Today is Thanksgiving in the United States. It isn’t a holiday we celebrate in the UK, and I’ve never been all that sure what the significance of it is.

Some searching online has unearthed that its origin was as part of a yearly harvest festival, with the thanks in question relating to being thankful for the blessings one enjoyed such as food, shelter etc.

Within the clinical trials industry, I would suggest the people most deserving of our gratitude are the trial participants, who give of their time and physiology to help further the cause of medical research.

I’ve said it before and will continue to do so – without patients taking part in trials, there would be no clinical trials industry, no big pharma companies, and ultimately no approved treatments for the vast range of diseases and conditions we are prone to as humans.

So let’s give thanks to trial participants on Thanksgiving.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...